- Generic name
- Methyl Prednisolone
- Strength
- 16 mg
- Dosage form
- Tablet
- Manufactured by
- Square Pharmaceuticals PLC.
Methigic 16 Tablet
About Methigic 16 Tablet
Methigic 16 is a tablet made by Square Pharmaceuticals PLC. It contains 16 mg of methylprednisolone, a glucocorticoid medicine. Doctors prescribe it for certain hormone, joint and inflammatory conditions, and the dose is set by the doctor.
There are 22 brands of Methyl Prednisolone listed in Bangladesh. The lowest listed price is Depodrol 2 mg Tablet at ৳ 3 per unit.
What is Methigic 16 Tablet?
Methigic 16 is a 16 mg tablet of methylprednisolone, a glucocorticoid made by Square Pharmaceuticals PLC. Glucocorticoids are steroid hormones that reduce inflammation and dampen immune system activity. Methylprednisolone also affects how the body handles salt and water, fats, proteins and carbohydrates, and it acts on muscle, the heart and blood vessels, the nervous system and the hormone system. Doctors use it in a range of conditions, including some hormone disorders and some joint and inflammatory problems. It is a prescription medicine, so the dose, the length of the course and any changes should always be decided by your doctor.
Uses of Methigic 16
Methigic 16 is used for certain endocrine (hormone) disorders, such as primary or secondary adrenocortical insufficiency, congenital adrenal hyperplasia, nonsuppurative thyroiditis and high calcium linked to cancer. It is also used for some rheumatic and joint problems, including rheumatoid arthritis, juvenile rheumatoid arthritis and ankylosing spondylitis, and for bursitis, synovitis of osteoarthritis and some tendon inflammation. Your doctor will confirm whether it suits your condition.
How to use Methigic 16
Take Methigic 16 exactly as your doctor tells you. The doctor decides the dose, how often you take it and how long the course lasts. Swallow the tablet with water, and follow any instructions your doctor gives about food or timing. Do not stop the medicine suddenly on your own, because the body may need to adjust. If you miss a dose or are unsure what to do, ask your doctor or pharmacist rather than changing the schedule yourself.
Side effects of Methigic 16
Short courses are often tolerated with few, mild side effects, but long-term or high-dose use can cause more serious problems. Watch for fluid retention, weight gain, raised blood pressure, low potassium, headache, muscle weakness and increased hair growth. Other effects are possible. Call your doctor if side effects bother you, if you notice swelling or unusual weight gain, or if you feel unwell. Seek urgent help for severe or sudden symptoms.
Safety and precautions
Methigic 16 is a prescription glucocorticoid, so ask your doctor before using it. In pregnancy it is classed as category C: it should be used only if the possible benefit justifies the possible risk to the baby. It has not been adequately studied in breastfeeding mothers, so discuss feeding with your doctor. Tell your doctor if you have an infection, thyroid problems, liver disease, eye herpes or blood-clotting problems, or if you take blood thinners or other medicines, as interactions are possible. Do not stop suddenly; the body may need time to recover.
Frequently asked questions
What is Methigic 16 used for, and what kind of medicine is it?
It is a glucocorticoid (steroid) tablet containing methylprednisolone. Doctors use it for certain hormone disorders and for some joint and inflammatory conditions, such as rheumatoid arthritis, bursitis and tendon inflammation. It is not suitable for everyone, so your doctor will decide whether it fits your condition.
Is Methigic 16 safe in pregnancy or while breastfeeding?
In pregnancy it is classed as category C, meaning it should be used only if the possible benefit justifies the possible risk to the baby. It has not been adequately evaluated in nursing mothers. Tell your doctor if you are pregnant, planning a pregnancy or breastfeeding, and let them decide.
What side effects should I watch for, and when should I call the doctor?
Watch for fluid retention, weight gain, raised blood pressure, low potassium, headache, muscle weakness and increased hair growth. Long-term or high-dose use can cause more serious effects. Call your doctor if these bother you or you feel unwell, and seek urgent help for severe or sudden symptoms.
Can I stop Methigic 16 suddenly on my own?
No. Do not stop it suddenly without asking your doctor, because the body may need to adjust after steroid treatment. Your doctor will decide how the dose is reduced and when to stop. Ask your pharmacist or doctor if you are unsure about any step of your course.
Indications
Rheumatic Disorders: Rheumatoid Arthritis. Juvenile Rheumatoid Arthritis, Ankylosing ... Read moreEndocrine Disorders: Primary or Secondary Adrenocortical Insufficiency, Congenital Adrenal Hyperplasia, Nonsuppurative Thyroiditis, Hypercalcemia associated with Cancer.
Rheumatic Disorders: Rheumatoid Arthritis. Juvenile Rheumatoid Arthritis, Ankylosing Spondylitis, Acute and Subacute Bursitis, Synovitis of Osteoarthritis, Acute nonspecific Tenosynovitis, Post-traumatic Osteoarthritis, Psoriatic Arthritis, Epicondylitis, Acute Gouty Arthritis.
Collagen Diseases: Systemic lupus Erythematosus, Systemic Dermatomyositis and Acute Rheumatic Carditis.
Dermatologic Diseases: Bullous Dermatitis Herpetiformis, Severe Erythema Multiforme (Stevens-Johnson syndrome), Severe Seborrheic Dermatitis, Exfoliative Dermatitis, Mycosis Fungoides, Pemphigus, Severe Psoriasis.
Allergy: Seasonal or Perennial Allergic Rhinitis, Drug hypersensitivity reactions, Serum Sickness, Contact Dermatitis, Bronchial Asthma and Atopic Dermatitis;
Ophthalmic Diseases: Allergic Corneal Ulcers, Herpes Zoster Ophthalmicus, Anterior segment inflammation, Sympathetic Ophthalmia, Keratitis, Optic Neuritis, Allergic Conjunctivitis, Chorioretinitis, iritis end iridocyclitis.
Respiratory Diseases: Symptomatic sarcoidosis, Loeffler's syndrome not manageable by other means, berylliosis, Aspiration Pneumonitis.
Hematological Disorders: Idiopathic Thrombocytopenic Purpura in adults, Secondary Thrombocytopenia in adults, Acquired (Autoimmune) Hemolytic Anemia, Erythroblastopenia, Congenital (Erythroid) Hypoplastic Anemia.
Neoplastic Diseases: For palliative management of Leukemias and Lymphomas in adults, Acute leukemia of childhood.
Edematous States: To induce a diuresis or remission of Proteinuria in the Nephrotic Syndrome, without Uremia, of the idiopathic type or that due to Lupus Erythematosus.
Gastrointestinal Disease: To tide the patient over a critical period of the disease in Ulcerative Colitis & Regional Enteritis.
CNS Disease: Acute Exacerbations of Multiple Sclerosis.
Pharmacology
protein, and carbohydrate metabolism, skeletal muscle, the cardiovascular system, the immune system, the nervous system, and the endocrine system.
Pharmacokinetic properties: The absolute bioavailability of Methylprednisclone is generally high (82% to 89%) following oral administration and rapidly absorbed and the maximum plasma concentration is achieved around 1.5 to 2.3 hours across doses following oral administration in normal healthy adults. Methylprednisolone is widely distributed into the tissues and its volume of distribution is 41-61.5 liter. It crosses the Wood-brain barrier and the placental barrier and is secreted in breast milk. The plasma protein binding of Methylprednisolone in humans is approximately 77%. Methylprednisolone is metabolized in the liver to inactive metabolites. No dosing adjustments are necessary for renal failure. Methylprednisolone is haemodializable.
Dosage & Administration
As anti-inflammatory or immunosuppressive initial dosage: As anti-inflammatory or immunosuppressive, the initial dosage of Methylprednisolone tablets may vary from 4-48 mg per day depending on the specific disease entity being treated, in situations of less severity lower doses will generally suffice while in selected patients higher initial doses may be required. The initial dosage should be maintained or adjusted until a satisfactory response is noted. If after a reasonable period of time there is a lack of satisfactory dirtied response, Methylprednisolone should be discontinued and the patient transferred to other appropriate therapy. It should be emphasized that dosage requirements are variable and must be Individualized on the basis of the disease under treatment and the response of the patient.
As anti-inflammatory or immunosuppressive maintenance dosage: After a favorable response is noted, the proper maintenance dosage should be determined by decreasing the initial drug dosage in small decrements at appropriate time intervals until the lowest dosage which will maintain an adequate clinical response is reached. It should be kept in mind that constant monitoring is needed in regard to drug dosage. If after long-term therapy the drug is to be stopped, it is recommended that it be withdrawn gradually rather than abruptly.
Multiple Sclerosis: In the treatment of acute exacerbations of multiple sclerosis, daily doses of 160 mg of Methylprednisolone for a week followed by 64 mg every other day for 1 month have been shown to be effective.
Methylprednisolone 4 mg tablet can be used to treat and to control severe allergy end dermatitis following the guideline listed below to minimize the steroid withdrawal syndromes:
- Day 1: 2 tablets before breakfast + 1 tablet after lunch + 1 tablet after dinner + 2 tablets at bedtime
- Day 2: 1 tablet before breakfast + 1 tablet after lunch + 1 tablet after dinner + 2 tablets at bedtime
- Day 3: 1 tablet before breakfast + 1 tablet after lunch + 1 tablet after dinner + 1 tablet at bedtime
- Day 4: 1 tablet before breakfast + 1 tablet after lunch + 1 tablet at bedtime
- Day 5: 1 tablet before breakfast + 1 tablet at bedtime
- Day 6: 1 tablet before breakfast
The following should be kept in mind when considering alternate-day therapy:
- Basic principles and indications for corticosteroid therapy should be applied.
- Alternate-day therapy is a therapeutic technique primarily designed for pefienis in whom long-term pharmacologic corticoid therapy is anticipated.
- In less severe disease processes in which corticoid therapy is indicated, it may be possible to initiate treatment with alternate-day therapy. More severe disease state usually will require daily divided high dose therapy for initiai control of the disease process. The initial suppressive dose level should be continued until a satisfactory clinical response is obtained, usually four to ten days in the case of many allergic and collagen diseases.
Interaction
Contraindications
Side Effects
Pregnancy & Lactation
Precautions & Warnings
Overdose Effects
Storage Conditions
Alternative brands of Methyl Prednisolone
Other brands with the same generic name, cheapest first.
Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.